İnce Barsak Anjiyodisplazi ve Multipl Miyeloma Bağlı Gelişen Tekrarlayan Gastrointestinal Kanamanın Talidomid ile Başarılı Tedavisi: Bir Taşla İki Kuş

Kaynakça (4)

1. Makris M, Federici AB, Mannucci PM, Bolton-Maggs PH, Yee TT, Abshire T, Berntorp E. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease. Haemophilia 2015;21:338-342. Duarte BKL, de Souza SM, Costa-Lima C, Medina SS, Ozelo MC. Thalidomide for the treatment of gastrointestinal bleeding due to angiodysplasia in a patient with Glanzmann’s thrombasthenia. Hematol Rep 2017;9:6961. Alam MA, Sami S, Babu S. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide. BMJ Case Rep 2011:2011.
2. Becq A, Rahmi G, Perrod G, Cellier C. Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management. Gastrointest Endosc 2017;86:792-806.
3. Ge ZZ, Chen HM, Gao YJ, Liu WZ, Xu CH, Tan HH, Chen HY, Wei W, Fang JY, Xiao SD. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011;141:1629-1637. Bauditz J. Effective treatment of gastrointestinal bleeding with thalidomide - chances and limitations. World J Gastroenterol 2016;22:3158-3164.
4. Kumar SK, Vij R, Noga SJ, Berg D, Brent L, Dollar L, Chari A. Treating multiple myeloma patients with oral therapies. Clin Lymphoma Myeloma Leuk 2017;17:243-251. Aguiar PM, de Mendonça Lima T, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Crit Rev Oncol Hematol 2017;113:195-212.